Health Reporter Jim Ritter published in the Chicago Sun-Times today “Pain Sufferer Turns to ‘Shrooms’.” The article describes the use of psilocybin as a treatment for cluster headaches and MAPS-initiated research at Harvard/McLean Hospital investigating LSD and psilocybin as treatment for subjects with cluster headache.
Originally appearing here.
August 16, 2006
BY JIM RITTER, Health Reporter
Every New Year’s Eve and July 4th, Bob Wold brews a tea containing a psychedelic drug from “magic mushrooms.”
Wold takes a small dose of the drug psilocybin — just enough to make sounds more distinct and colors a bit brighter. “I get a couple giggles out of it,” he said. “It’s like having two or three beers.”
But Wold doesn’t take “shrooms” for the four-hour high. Rather, he has found that psilocybin is the only drug that prevents one of the most painful conditions known to man, cluster headaches.
Wold, a 53-year-old construction contractor, began suffering cluster headaches about 25 years ago. He would get four to six headaches a day, each lasting 45 to 60 minutes. Each cluster period would last three or four months. “The pain is similar to if you hit your thumb with a hammer,” he said.
Five or six years ago, Wold read an Internet posting from a man who said his cluster headaches went away after he took LSD for recreational purposes. Word spread, and other patients began taking LSD or psilocybin.
LSD can cause vivid hallucinations and distortions of color, sound, touch, etc. It also can impair judgment, leading to injury. Afterwards, users can suffer acute anxiety or depression. Psilocybin can cause vivid distortions of sights and sounds and emotional disturbances, according to the U.S. Drug Enforcement Administration.
Wold had tried about 75 legal drugs, but none worked very long. Figuring he had nothing to lose, he tried psilocybin, and found that two doses a year worked wonders. He orders spores over the Internet and grows mushrooms at his Lombard home.
“For the past five years, I’ve been pretty much pain-free and headache-free,” he said.
Wold has formed a support group, ClusterBusters, to promote research on psychedelics. The group has heard from about 400 patients who have used psilocybin or LSD.
In a preliminary study, researchers from Harvard’s McLean Hospital surveyed patients who had used psilocybin or LSD. Twenty-five of 48 psilocybin users and seven of eight LSD users reported the drugs prevented the entire cluster period when headaches normally occurred.
“No other medication, to our knowledge, has been reported to terminate a cluster period,” researchers wrote in the June 27 issue of the journal Neurology.
No one knows why psychedelics might work. But Harvard researcher Dr. John Halpern noted that the drugs share a similar structure to medications that have been approved for cluster headaches.
However, researchers acknowledged several limitations to their study, including the possibility that people with good outcomes were more likely to participate than those with poor outcomes.
Halpern and colleagues are planning a follow-up study in which a psychedelic drug would be compared to an inactive placebo.
Psilocybin and LSD are Schedule 1 drugs, meaning they are illegal unless used in research approved by the DEA and Food and Drug Administration.
Halpern warns that psilocybin and LSD “are drugs of abuse and are potentially quite dangerous. . . . My advice then is to not self-medicate but to respect our laws and to help us properly and safely conduct the research needed to find out if these substances work for real.”
Jim Ritter can be reached at firstname.lastname@example.org